🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/12/2001 | 56,82 | 56,95 | 56,07 | 56,11 | -1,21% | 1,54% | 5.665.069 |
| 28/12/2001 | 56,92 | 57,18 | 56,67 | 56,79 | -0,43% | 0,89% | 4.161.608 |
| 27/12/2001 | 56,32 | 57,04 | 56,15 | 57,04 | -0,28% | 1,58% | 5.380.642 |
| 26/12/2001 | 57,28 | 57,63 | 56,83 | 57,20 | -0,13% | 1,40% | 4.745.763 |
| 24/12/2001 | 56,97 | 57,39 | 56,92 | 57,28 | +0,67% | 0,82% | 2.718.093 |
| 21/12/2001 | 57,44 | 57,47 | 56,77 | 56,90 | -0,20% | 1,21% | 9.449.502 |
| 20/12/2001 | 56,61 | 57,41 | 56,00 | 57,01 | +0,71% | 2,49% | 7.212.022 |
| 19/12/2001 | 55,83 | 57,25 | 55,73 | 56,61 | +1,42% | 2,73% | 10.680.902 |
| 18/12/2001 | 55,33 | 56,18 | 54,64 | 55,82 | +2,33% | 2,79% | 9.670.525 |
| 17/12/2001 | 55,90 | 56,20 | 54,20 | 54,55 | -1,58% | 3,58% | 11.281.930 |
| 14/12/2001 | 55,49 | 55,72 | 55,12 | 55,43 | +0,26% | 1,07% | 8.121.371 |
| 13/12/2001 | 55,87 | 57,11 | 54,87 | 55,29 | -0,99% | 4,01% | 14.345.129 |
| 12/12/2001 | 57,97 | 57,97 | 54,86 | 55,84 | -3,59% | 5,37% | 34.441.577 |
| 11/12/2001 | 64,36 | 64,46 | 57,07 | 57,92 | -9,39% | 11,48% | 21.704.918 |
| 10/12/2001 | 63,60 | 64,79 | 63,17 | 63,92 | -0,01% | 2,55% | 7.368.383 |
| 07/12/2001 | 63,12 | 63,93 | 63,08 | 63,93 | +1,29% | 1,35% | 5.302.356 |
| 06/12/2001 | 63,46 | 63,93 | 63,02 | 63,12 | -0,14% | 1,43% | 5.804.034 |
| 05/12/2001 | 64,20 | 64,20 | 62,50 | 63,21 | -2,06% | 2,65% | 7.216.947 |
| 04/12/2001 | 65,36 | 65,43 | 63,93 | 64,53 | -1,27% | 2,29% | 4.667.058 |
| 03/12/2001 | 64,07 | 65,36 | 63,79 | 65,36 | +1,11% | 2,46% | 5.402.964 |
| 30/11/2001 | 63,93 | 65,01 | 63,93 | 64,65 | +1,35% | 1,69% | 5.919.838 |
| 29/11/2001 | 63,07 | 63,83 | 62,83 | 63,79 | +2,30% | 1,57% | 5.056.810 |
| 28/11/2001 | 63,65 | 63,90 | 62,26 | 62,36 | -1,86% | 2,58% | 4.634.990 |
| 27/11/2001 | 63,98 | 64,77 | 62,98 | 63,54 | -0,69% | 2,80% | 5.263.475 |
| 26/11/2001 | 62,83 | 64,90 | 62,75 | 63,98 | +1,70% | 3,42% | 6.490.054 |
| 23/11/2001 | 62,58 | 63,10 | 62,02 | 62,91 | +0,53% | 1,72% | 2.452.530 |
| 21/11/2001 | 61,20 | 62,61 | 61,12 | 62,58 | +2,25% | 2,45% | 4.760.750 |
| 20/11/2001 | 61,07 | 61,64 | 60,97 | 61,20 | -0,70% | 1,09% | 5.740.525 |
| 19/11/2001 | 61,55 | 61,68 | 60,83 | 61,63 | -0,48% | 1,38% | 7.126.819 |
| 16/11/2001 | 62,21 | 62,40 | 61,12 | 61,93 | +0,37% | 2,06% | 5.739.686 |